Investigational Drug Information for Pafuramidine
✉ Email this page to a colleague
What is the drug development status for Pafuramidine?
Pafuramidine is an investigational drug.
There have been 4 clinical trials for Pafuramidine.
The most recent clinical trial was a Phase 2 trial, which was initiated on May 1st 2006.
The most common disease conditions in clinical trials are Trypanosomiasis, African, Trypanosomiasis, and Pneumonia. The leading clinical trial sponsors are Immtech Pharmaceuticals, Inc, Bill and Melinda Gates Foundation, and [disabled in preview].
Summary for Pafuramidine
| US Patents | 0 |
| International Patents | 0 |
| US Patent Applications | 29 |
| WIPO Patent Applications | 16 |
| Japanese Patent Applications | 1 |
| Clinical Trial Progress | Phase 2 (2006-05-01) |
| Vendors | 29 |
Recent Clinical Trials for Pafuramidine
| Title | Sponsor | Phase |
|---|---|---|
| Randomized, Double-Blind Phase 1 Safety and Tolerability Study of Pafuramidine Maleate (DB289) in Healthy Subjects | Immtech Pharmaceuticals, Inc | Phase 1 |
| DB289 Versus TMP-SMX for the Treatment of Acute Pneumocystis Jiroveci Pneumonia (PCP) | Immtech Pharmaceuticals, Inc | Phase 3 |
| Trial of DB289 for the Treatment of Stage I African Trypanosomiasis | Bill and Melinda Gates Foundation | Phase 2 |
Clinical Trial Summary for Pafuramidine
Top disease conditions for Pafuramidine
Top clinical trial sponsors for Pafuramidine
US Patents for Pafuramidine
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
